RAGE deficiency improves postinjury sciatic nerve regeneration in type 1 diabetic mice

Diabetes

Volumn 62, Issue 3, 2013, Pages 931-943

  Juranek, Judyta K ^a   Geddis, Matthew S ^a,b   Song, Fei ^a   Zhang, Jinghua ^a   Garcia, Jose ^c   Rosario, Rosa ^a   Yan, Shi Fang ^a   Brannagan, Thomas H ^c   Schmidt, Marie ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEW YORK   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; PROTEIN M2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL FUNCTION; CONTROLLED STUDY; GENE EXPRESSION; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE; MALE; MOUSE; NERVE FIBER REGENERATION; NERVE REGENERATION; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; SCIATIC NERVE; SCIATIC NERVE INJURY; SIGNAL TRANSDUCTION; UPREGULATION; VELOCITY;

ANIMALS; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; GLYCOSYLATION END PRODUCTS, ADVANCED; IMMUNOHISTOCHEMISTRY; LIGANDS; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE CRUSH; NERVE REGENERATION; NEURAL CONDUCTION; ORGAN SPECIFICITY; RECEPTORS, IMMUNOLOGIC; SCIATIC NERVE; SCIATIC NEUROPATHY;

EID: 84874439683     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-0632     Document Type: Article

References (46)

1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4-14
2. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414:782-787
3. Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of diabetes and diabetes-related complications. Phys Ther 2008;88:1254-1264
4. Candrilli SD, Davis KL, Kan HJ, Lucero MA, Rousculp MD. Prevalence and the associated burden of illness of symptoms of diabetic peripheral neuropathy and diabetic retinopathy. J Diabetes Complications 2007;21:306-314
5. Hall V, Thomsen RW, Henriksen O, Lohse N. Diabetes in Sub Saharan Africa 1999-2011: Epidemiology and public health implications. A systematic review. BMC Public Health 2011;11:564
6. Viswanathan V, Kumpatla S. Pattern and causes of amputation in diabetic patients-a multicentric study from India. J Assoc Physicians India 2011; 59:148-151
7. Boulton AJ. What you can't feel can hurt you. J Vasc Surg 2010;52(Suppl): 28S-30S
8. Putz Z, Nadas J, Jermendy G. Severe but preventable foot burn injury in diabetic patients with peripheral neuropathy. Med Sci Monit 2008;14:CS89-CS91
9. Liniger C, Albeanu A, Moody JF, Richez J, Bloise D, Assal JP. The Thermocross: A simple tool for rapid assessment of thermal sensation thresholds. Diabetes Res Clin Pract 1991;12:25-33
10. Dijkstra S, vd Bent MJ, vd Brand HJ, et al. Diabetic patients with foot burns. Diabet Med 1997;14:1080-1083
11. Polydefkis M, Hauer P, Sheth S, Sirdofsky M, Griffin JW, McArthur JC. The time course of epidermal nerve fibre regeneration: Studies in normal controls and in people with diabetes, with and without neuropathy. Brain 2004;127:1606-1615
12. Ebenezer GJ, O'Donnell R, Hauer P, Cimino NP, McArthur JC, Polydefkis M. Impaired neurovascular repair in subjects with diabetes following experimental intracutaneous axotomy. Brain 2011;134:1853-1863
13. Kennedy JM, Zochodne DW. The regenerative deficit of peripheral nerves in experimental diabetes: Its extent, timing and possible mechanisms. Brain 2000;123:2118-2129
14. Bierhaus A, Haslbeck K-M, Humpert PM, et al. Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. J Clin Invest 2004;114:1741-1751
15. Toth C, Rong LL, Yang C, et al. Receptor for advanced glycation end products (RAGEs) and experimental diabetic neuropathy. Diabetes 2008; 57:1002-1017
16. Yan SF, Ramasamy R, Schmidt AM. Mechanisms of disease: Advanced glycation endproducts and their receptor in inflammation and diabetes complications. Nat Rev Endocrinol 2008;4:285-293
17. Barlovic DP, Soro-Paavonen A, Jandeleit-Dahm KA. RAGE biology, atherosclerosis and diabetes. Clin Sci (Lond) 2011;121:43-55
18. Yan SF, Ramasamy R, Schmidt AM. Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response. J Mol Med (Berl) 2009;87:235-247
19. Hofmann MA, Drury S, Fu C, et al. RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100/calgranulin polypeptides. Cell 1999;97:889-901
20. Taguchi A, Blood DC, del Toro G, et al. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 2000;405: 354-360
21. Cataldegirmen G, Zeng S, Feirt N, et al. RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-alpha and NFkappaB. J Exp Med 2005;201:473-484
22. Zeng S, Zhang QY, Huang J, et al. Opposing roles of RAGE and Myd88 signaling in extensive liver resection. FASEB J 2012;26:882-893
23. Rong LL, Yan SF, Wendt T, et al. RAGE modulates peripheral nerve regeneration via recruitment of both inflammatory and axonal outgrowth pathways. FASEB J 2004;18:1818-1825
24. Rong LL, Trojaborg W, Qu W, et al. Antagonism of RAGE suppresses peripheral nerve regeneration. FASEB J 2004;18:1812-1817
25. Fazan VP, Salgado HC, Barreira AA. A descriptive and quantitative light and electron microscopy study of the aortic depressor nerve in normotensive rats. Hypertension 1997;30:693-698
26. Hunter DA, Moradzadeh A, Whitlock EL, et al. Binary imaging analysis for comprehensive quantitative histomorphometry of peripheral nerve. J Neurosci Methods 2007;166:116-124
27. Mayhew TM, Sharma AK. Sampling schemes for estimating nerve fibre size. I. Methods for nerve trunks of mixed fascicularity. J Anat 1984;139: 45-58
28. Said G, Lacroix C, Lozeron P, Ropert A, Planté V, Adams D. Inflammatory vasculopathy in multifocal diabetic neuropathy. Brain 2003;126:376-385
29. Shan X, Chiang PM, Price DL, Wong PC. Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice. Proc Natl Acad Sci USA 2010;107:16325-16330
30. Narasimhan SD, Yen K, Bansal A, Kwon ES, Padmanabhan S, Tissenbaum HA. PDP-1 links the TGF-b and IIS pathways to regulate longevity, development, and metabolism. PLoS Genet 2011;7:e1001377
31. Gerrits MF, Ghosh S, Kavaslar N, et al. Distinct skeletal muscle fiber characteristics and gene expression in diet-sensitive versus diet-resistant obesity. J Lipid Res 2010;51:2394-2404
32. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-D D C(T)) Method. Methods 2001;25: 402-408
33. Fu SY, Gordon T. The cellular and molecular basis of peripheral nerve regeneration. Mol Neurobiol 1997;14:67-116
34. Lawrence T, Natoli G. Transcriptional regulation of macrophage polarization: Enabling diversity with identity. Nat Rev Immunol 2011;11:750-761
35. Geissmann F, Gordon S, Hume DA, Mowat AM, Randolph GJ. Unravelling mononuclear phagocyte heterogeneity. Nat Rev Immunol 2010;10:453-460
36. Chavakis T, Bierhaus A, Al-Fakhri N, et al. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: A novel pathway for inflammatory cell recruitment. J Exp Med 2003;198:1507-1515
37. Reiniger N, Lau K, McCalla D, et al. Deletion of the receptor for advanced glycation end products reduces glomerulosclerosis and preserves renal function in the diabetic OVE26 mouse. Diabetes 2010;59:2043-2054
38. Thornalley PJ. Glyoxalase I-structure, function and a critical role in the enzymatic defence against glycation. Biochem Soc Trans 2003;31:1343-1348
39. Anderson MM, Requena JR, Crowley JR, Thorpe SR, Heinecke JW. The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl) lysine on proteins: A mechanism for producing advanced glycation end products at sites of inflammation. J Clin Invest 1999;104:103-113
40. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002;418:191-195
41. Park L, Raman KG, Lee KJ, et al. Suppression of accelerated diabetic atherosclerosis by soluble receptor for advanced glycation endproducts. Nat Med 1998;4:1025-1031
42. Ohgami N, Nagai R, Ikemoto M, et al. Cd36, a member of the class b scavenger receptor family, as a receptor for advanced glycation end products. J Biol Chem 2001;276:3195-3202
43. Eto M, Sumi H, Fujimura H, Yoshikawa H, Sakoda S. Pioglitazone promotes peripheral nerve remyelination after crush injury through CD36 upregulation. J Peripher Nerv Syst 2008;13:242-248
44. Terada M, Yasuda H, Kikkawa R. Delayed Wallerian degeneration and increased neurofilament phosphorylation in sciatic nerves of rats with streptozocin-induced diabetes. J Neurol Sci 1998;155:23-30
45. Parathath S, Grauer L, Huang LS, et al. Diabetes adversely affects macrophages during atherosclerotic plaque regression in mice. Diabetes 2011; 60:1759-1769
46. O'Brien J, Lyons T, Monks J, et al. Alternatively activated macrophages and collagen remodeling characterize the postpartum involuting mammary gland across species. Am J Pathol 2010;176:1241-1255